Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.
Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: momota m. Cancers (Basel). 2023 Feb 27;15(5):1489. doi: 10.3390/cancers15051489. Cancers (Basel). 2023. PMID: 36900280 Free PMC article.
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C. Kodama H, et al. Among authors: momota m. Oncotarget. 2017 Aug 24;8(47):83183-83194. doi: 10.18632/oncotarget.20554. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137333 Free PMC article.
Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.
Horiguchi H, Hatakeyama S, Anan G, Kubota Y, Kodama H, Momota M, Kido K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C. Horiguchi H, et al. Among authors: momota m. Oncotarget. 2018 Jan 4;9(9):8746-8755. doi: 10.18632/oncotarget.23982. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492234 Free PMC article.
Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C. Momota M, et al. Oncotarget. 2018 May 1;9(33):23047-23057. doi: 10.18632/oncotarget.25198. eCollection 2018 May 1. Oncotarget. 2018. PMID: 29796171 Free PMC article.
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C. Soma O, et al. Among authors: momota m. Med Oncol. 2019 Sep 13;36(10):88. doi: 10.1007/s12032-019-1313-x. Med Oncol. 2019. PMID: 31520152 Clinical Trial.
Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: momota m. Urol Oncol. 2020 Aug;38(8):684.e1-684.e8. doi: 10.1016/j.urolonc.2020.02.001. Epub 2020 Mar 20. Urol Oncol. 2020. PMID: 32201059
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: momota m. Urol Oncol. 2020 Aug;38(8):684.e17-684.e24. doi: 10.1016/j.urolonc.2020.03.009. Epub 2020 Apr 9. Urol Oncol. 2020. PMID: 32278732
52 results